Two Sigma Advisers’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-113,600
Closed -$100K 2579
2024
Q2
$100K Buy
113,600
+12,100
+12% +$24.9K ﹤0.01% 2321
2024
Q1
$415K Sell
101,500
-134,300
-57% -$601K ﹤0.01% 1947
2023
Q4
$1.38M Buy
+235,800
New +$1.24M ﹤0.01% 1475

Other funds holding AUGX

Two Sigma Advisers's AUGX Position: Q3 2024 in Review

Two Sigma Advisers sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 113,600 shares — an estimated $100K sold.

Two Sigma Advisers first reported a position in AUGX in Q4 2023 and held it in 3 quarters. The position peaked at $1.38M in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Two Sigma Advisers reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 113,600 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $100K.
  • Two Sigma Advisers first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Two Sigma Advisers's Augmedix, Inc. Common Stock position peaked at $1.38M in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.